PL212010B1 - Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej - Google Patents

Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej

Info

Publication number
PL212010B1
PL212010B1 PL356784A PL35678401A PL212010B1 PL 212010 B1 PL212010 B1 PL 212010B1 PL 356784 A PL356784 A PL 356784A PL 35678401 A PL35678401 A PL 35678401A PL 212010 B1 PL212010 B1 PL 212010B1
Authority
PL
Poland
Prior art keywords
diacerein
psoriasis
treatment
pharmaceutical composition
arthritis
Prior art date
Application number
PL356784A
Other languages
English (en)
Polish (pl)
Other versions
PL356784A1 (pl
Inventor
Napoli Guido Di
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of PL356784A1 publication Critical patent/PL356784A1/xx
Publication of PL212010B1 publication Critical patent/PL212010B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL356784A 2000-01-12 2001-01-08 Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej PL212010B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH532000 2000-01-12
PCT/IB2001/000005 WO2001051044A2 (fr) 2000-01-12 2001-01-08 Substances utilisees dans le traitement du psoriasis

Publications (2)

Publication Number Publication Date
PL356784A1 PL356784A1 (pl) 2004-07-12
PL212010B1 true PL212010B1 (pl) 2012-07-31

Family

ID=4291590

Family Applications (1)

Application Number Title Priority Date Filing Date
PL356784A PL212010B1 (pl) 2000-01-12 2001-01-08 Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej

Country Status (22)

Country Link
US (2) US6844365B2 (fr)
EP (1) EP1248608B1 (fr)
JP (1) JP4912554B2 (fr)
CN (1) CN1187045C (fr)
AR (1) AR026801A1 (fr)
AT (1) ATE254913T1 (fr)
AU (1) AU776324B2 (fr)
BR (2) BR0107493A (fr)
CA (1) CA2396111C (fr)
CZ (1) CZ301129B6 (fr)
DE (1) DE60101309T2 (fr)
DK (1) DK1248608T3 (fr)
ES (1) ES2210120T3 (fr)
IL (2) IL150390A0 (fr)
MX (1) MXPA02006610A (fr)
PL (1) PL212010B1 (fr)
PT (1) PT1248608E (fr)
RU (1) RU2266740C2 (fr)
SK (1) SK286589B6 (fr)
TR (1) TR200400228T4 (fr)
WO (1) WO2001051044A2 (fr)
ZA (1) ZA200205148B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128317A1 (en) * 2001-01-23 2002-09-12 Laboratories Negma Treatment of pathological conditions characterized by an increased IL-1 level
CN1321636C (zh) * 2002-12-30 2007-06-20 北京大学第一医院 大黄酸在抑制血管生成中的应用
NZ595225A (en) 2005-05-16 2013-05-31 Abbott Biotech Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
WO2008063213A2 (fr) * 2006-04-10 2008-05-29 Abbott Biotechnology Ltd. Compositions destinées au traitement de la polyarthrite psoriasique et leurs applications
US20080085912A1 (en) * 2006-10-06 2008-04-10 Unitech Pharmaceuticals, Inc. Isoxazole derivatives and methods of treating diseases
EP2060562A1 (fr) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dérivés de sulfonate de dioxoanthracène
WO2009133430A1 (fr) * 2008-04-30 2009-11-05 Wockhardt Research Centre Compositions topiques de rhéine ou de diacéréine
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
KR101567925B1 (ko) * 2010-04-08 2015-11-10 티더블유아이 바이오테크놀로지 인코포레이티드 당뇨병 보조치료요법으로서 디아세레인을 사용하는 방법
US20180311199A1 (en) * 2016-01-12 2018-11-01 Lawrence Chan Combination treatment for inflammatory diseases
CN106236729A (zh) * 2016-07-31 2016-12-21 合肥远志医药科技开发有限公司 一种双醋瑞因胶囊制剂及其制备方法
CN106692109A (zh) * 2017-01-02 2017-05-24 佛山市腾瑞医药科技有限公司 一种微孔膜控释包衣双醋瑞因微丸及其制备方法
JP2020505362A (ja) 2017-01-19 2020-02-20 ティダブリューアイ・バイオテクノロジー・インコーポレイテッドＴＷＩ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． 免疫炎症性皮膚障害を予防または治療するための方法および医薬組成物
CN106619555A (zh) * 2017-02-14 2017-05-10 佛山市腾瑞医药科技有限公司 一种双醋瑞因速释微丸制剂、制备方法
CN106667954A (zh) * 2017-02-14 2017-05-17 佛山市腾瑞医药科技有限公司 一种双醋瑞因软胶囊制剂及其制备工艺
CN106727360A (zh) * 2017-02-16 2017-05-31 佛山市腾瑞医药科技有限公司 一种双醋瑞因固体分散体制剂及其制备方法
KR102938542B1 (ko) * 2018-03-29 2026-03-13 에스.아이.에스. 슐로브 이노베이티브 사이언스 리미티드 염증성 시토카인을 억제하기 위한 약제학적 조성물
WO2021011538A1 (fr) * 2019-07-15 2021-01-21 R.P. Scherer Technologies, Llc Formes galéniques capsules, leurs procédés de préparation et leurs procédés d'utilisation
CN112755013A (zh) * 2021-02-22 2021-05-07 北京市中医研究所 大黄酸作为s100a8的抑制剂在炎症性疾病中的制药应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
IT1264545B1 (it) 1993-07-30 1996-10-02 Medidom Lab Procedimento per la preparazione della diacereina
IT1282381B1 (it) 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
IT1283771B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di derivati della reina
IT1283772B1 (it) 1996-07-31 1998-04-30 Medidom Lab Procedimento per la preparazione di reina e diacereina
JP4049406B2 (ja) * 1996-10-15 2008-02-20 正規 小菅 津液改善剤及びそれを含有する経口投与用組成物
JP4018764B2 (ja) * 1996-10-18 2007-12-05 正規 小菅 津液改善用皮膚外用剤
JPH10129556A (ja) 1996-10-28 1998-05-19 Fumiaki Mori 盗難防止自転車
FR2757397B1 (fr) * 1996-12-23 1999-03-05 Mazal Pharma Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree
IT1297038B1 (it) 1997-12-30 1999-08-03 Medidom Lab Procedimento per la preparazione di reina e suoi diacilderivati

Also Published As

Publication number Publication date
JP2003519653A (ja) 2003-06-24
IL150390A (en) 2007-07-24
WO2001051044A2 (fr) 2001-07-19
ZA200205148B (en) 2003-06-26
US6844365B2 (en) 2005-01-18
ES2210120T3 (es) 2004-07-01
MXPA02006610A (es) 2004-09-10
PL356784A1 (pl) 2004-07-12
ATE254913T1 (de) 2003-12-15
US20050004045A1 (en) 2005-01-06
PT1248608E (pt) 2004-04-30
CN1395484A (zh) 2003-02-05
JP4912554B2 (ja) 2012-04-11
AU776324B2 (en) 2004-09-02
DE60101309D1 (de) 2004-01-08
TR200400228T4 (tr) 2004-02-23
EP1248608B1 (fr) 2003-11-26
CN1187045C (zh) 2005-02-02
CA2396111A1 (fr) 2001-07-19
RU2266740C2 (ru) 2005-12-27
SK286589B6 (sk) 2009-01-07
EP1248608A2 (fr) 2002-10-16
BR0107493A (pt) 2002-10-08
AR026801A1 (es) 2003-02-26
DK1248608T3 (da) 2004-04-05
DE60101309T2 (de) 2004-09-16
CZ301129B6 (cs) 2009-11-11
WO2001051044A3 (fr) 2002-03-28
IL150390A0 (en) 2002-12-01
US20020143057A1 (en) 2002-10-03
SK9912002A3 (en) 2003-02-04
BRPI0107493B1 (pt) 2019-04-16
CA2396111C (fr) 2008-12-02
AU2213201A (en) 2001-07-24
BRPI0107493B8 (pt) 2021-05-25
CZ20022382A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
PL212010B1 (pl) Zastosowanie diacereiny lub jej farmaceutycznie dopuszczalnej pochodnej
TWI331920B (en) Unit dosage form for relieving or treating constipation in human patients
WO2005034936A1 (fr) Utilisation de l-butylphtalide dans la fabrication de medicaments destines a la prevention et au traitement de l'infarctus cerebral
EP0629400A1 (fr) Compositions contenant de l'idebenone pour le traitement de la maladie d'Alzheimer
JPH0667842B2 (ja) 基本的うつ病を軽減するためのうつ病治療剤
TW202116297A (zh) 組合療法之方法、組成物與套組
WO2023202989A1 (fr) Traitement de l'alopécie fibrosante frontale
EP3851104A1 (fr) Combinaison pharmaceutique synergique d'un inhibiteur sélectif de la cyclooxygénase 2 et d'un dérivé d'anthraquinone
KR101072175B1 (ko) 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 배뇨장애 치료제 및 부종 치료제조성물
CN115607588B (zh) 一种标本兼治抗痛风的芹槐提取物与非布司他药物组合物及其用途
CN110279691B (zh) 一种外科术后护理镇痛药物及其用途
AB Summary of product characteristics
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
CN113133997B (zh) 一种含小檗碱的药物组合物及其用途
CN109045054A (zh) 七叶皂苷的新用途
WO2023220396A1 (fr) Procédés de traitement utilisant un inhibiteur de kinase 1a à double spécificité régulée par la phosphorylation de la tyrosine (dyrk1a)
CN119587533A (zh) 一种抗氧化剂α-硫辛酸在制备改善胃炎的药物中的应用
EP1793818A2 (fr) Pindolol pour le traitement du syndrome et du trouble dysphorique premenstruel
PL243152B1 (pl) Zastosowanie perampanelu w profilaktyce i leczeniu czerniaka oraz kompozycja farmaceutyczna
CN103690555A (zh) 一种治疗乙酰胆碱性荨麻疹的药物组合物
CN113230255A (zh) 阿帕替尼在制备防治nlrp3炎症小体相关疾病的药物中的应用
JPH04169534A (ja) 前立腺肥大症治療剤
MXPA98001222A (en) Quecontain composition mefenamic acid in association with code
JPH0643335B2 (ja) 緩下剤
EP0293529A1 (fr) Mélanges de diflunisal et de trométhamine